Posted August 28, 2019
Healthcare startup Gemstone Biotherapeutics gets Maryland Momentum Fund investment
The Baltimore-based company earned $250,000 from the fund, which was created to support University System of Maryland-affiliated startups.
Baltimore-based Gemstone Therapeutics has received $250,000 in a new investment from the Maryland Momentum Fund.
The investment from the fund, which was created by the University System of Maryland to support startups created by students, faculty, alums and other affiliates, is part of a new funding round for Gemstone, according to the fund.
Gemstone CEO Emily English earned a bachelor’s degree from the University of Maryland College Park, and board chairman and noted investor and entrepreneur David Oros received his bachelor’s degree from UMBC.